Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With… (NCT04789876) | Clinical Trial Compass
CompletedNot Applicable
Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia
Malaysia74 participantsStarted 2019-11-01
Plain-language summary
This multi-centred randomized, open label-controlled trial consists of hemodialysis (HD) patients identified with hyperphosphatemia (\>1.78mmol/L). The intervention group received a phosphate mobile app and the control group received one-off dietary counselling for 12 weeks. Serum phosphate was measured pre-and post-intervention.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 18 years old and above.
* Patients were undergoing maintenance HD treatment for more than three months.
* Patients were on hemodialysis treatment for 4 hours per session, three times a week.
* Kt/V value (a numerical formula value to determine hemodialysis treatment adequacy. K is dialyser clearance of urea, t is dialysis time, and V is the volume of distribution of urea, approximately equal to the patient's total body water) is 1.2 and above each session.
* Patients were able to read English or Malay or Mandarin.
* Patients were on the single type of phosphate binder.
* Patients were having serum phosphorus above 1.78mmol/l and above for more than three months.
* Patients were not seen by a dietitian for the past one year for phosphate education.
* Patients did not have ward admission for the past three months.
* Patients did not have dementia or developmental delay.
* Patients owned and able to use a smartphone.
* Patients were able to use at least one comprehensive mobile application independently.
* Patients had access to the internet/data plan.
* Patients were willing to adhere to all study requirements and protocol.
* Patients were willing to accept the publication of data without exposing their name.
Exclusion Criteria:
* Patients were on incremental or acute hemodialysis.
* Patients had ward admission three months prior to the study and during the study period.
* Patients were terminally ill.
* Patients had cognitive impairment o…